$CHRW

C.H. Robinson Stock: Is Wall Street Bullish or Bearish?

JPMorgan analyst Brian Ossenbeck raised C.H. Robinson’s (CHRW) price target to $225 on Jul. 30 while keeping an “Overweight” rating, according to the article. The mean target is $203.28, about a 37.1% premium to the current price, and the Street-high is $237, implying about 59.8% upside. The stock has 15 “Strong Buy” ratings.

Original reporting
Published Aug 12, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 9:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
C.H. Robinson Stock: Is Wall Street Bullish or Bearish? — source image
Decision brief

The 30-second read

$CHRWBullishLow
01

Why it matters

For traders, the only concrete new input is the updated JPMorgan price target ($225) with an unchanged Overweight rating; the rest is rating aggregation and implied upside math.

02

Market read

Bullish sentiment tilt for CHRW driven by a higher sell-side target, with no new fundamental disclosures in the text.

03

What to watch

The article does not state the thesis behind the target change, nor does it provide any new CHRW operational metrics.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session positioning based on the Jul. 30 JPMorgan target raise

Background

The piece frames CHRW as increasingly bullish on Wall Street, citing Strong Buy counts and a JPMorgan target increase from Jul. 30.

Company-level read

Ticker impact

$CHRWBullishMedium confidence
Context

JPMorgan raised C.H. Robinson’s price target to $225 and kept an Overweight rating, implying a 37% to 60% upside versus current levels.

Expected impact

Near-term bias modestly positive, but likely limited because it is an analyst target change rather than new company fundamentals.

Evidence & confidence

A specific, attributable target increase is actionable for positioning, but the text provides no new earnings, guidance, or operational catalyst.

Market effects

Limited sector read-through since the article contains only a single-name analyst target update.

No regional macro or cross-market linkage described.

No global supply-chain or international catalyst mentioned.

Counterpoint

Analyst target hikes can fade if they are not accompanied by new company guidance, earnings beats, or order-flow data.

Key entities

  • C.H. Robinson

    Subject of the article, discussed via analyst rating and price-target changes.

  • JPMorgan analyst Brian Ossenbeck

    Raised CHRW’s price target to $225 while maintaining Overweight.

Related articles

$CHRWMed

C.H. Robinson reports 20% increase in adjusted operating income

C.H. Robinson (CHRW) said Q2 2026 adjusted operating income rose 20% year over year as its transformation continued amid weaker freight demand. It reported NAST operating margin (ex restructuring) up 280 bps to 40.9% and Global Forwarding up 470 bps to 33.4%. The company returned $301 million via dividends and buybacks.

$GXOMed

Logistics giants lift profits despite weak freight demand

Logistics groups reported profit growth despite weak freight demand. DSV said Q2 revenue rose to DKK 76.7bn and EBIT before special items to DKK 6.26bn on Schenker integration. Kuehne+Nagel lifted Q2 net turnover to CHF 6.6bn and raised its 2026 operating EBIT forecast. DHL revenue rose to €22.4bn with EBIT up 30% to €1.9bn. GXO and C.H. Robinson also posted higher earnings.

$CHRWMed

C.H. Robinson Extends Multi-Year Outperformance in Q2 2026 as Lean AI Transformation Delivers Results

C.H. Robinson reported Q2 2026 results showing continued operating margin targets amid a year-over-year decline in the Cass Freight Shipment Index for the 15th straight quarter. The company said adjusted operating income rose 20% YoY, NAST operating margin (ex restructuring) rose to 40.9% and Global Forwarding to 33.4%, and it returned $301 million to shareholders.

$CHRWMed

Trucking Stocks Fall on Legal Risk in Worst Month Since Tariffs

Trucking and logistics stocks are set for their worst month in over a year as legal risk rises after a Dallas County jury preliminary verdict against CH Robinson Worldwide, tied to a May Supreme Court ruling that may enable lawsuits against brokers for injuries from motor carriers. CH Robinson shares are down 21% this month; RXO and Landstar also fell amid weak earnings and outlooks.